MarkRLaftaviMD

PubMed

• 1 citations
  A new model to determine Optimal Exposure to Tacrolimus and Mycophenolate Mofetil after renal transplantation.
  O. Pankewycz, Engin Onan, Dane Rucker, Dongliang Wang, Angelika C. Gruessner, Rainer W.G. Gruessner, Mark R. Laftavi> ;Clinical Transplantation. 2020 May 4
• 20 citations
  Surgery of pancreas transplantation.
  Mark R. Laftavi, Angelika C. Gruessner, Rainer W.G. Gruessner> ;Current Opinion in Organ Transplantation. 2017 Aug 1
• 28 citations
  Simultaneous Pancreas and Kidney Transplantation-Is It a Treatment Option for Patients With Type 2 Diabetes Mellitus? An Analysis of the International Pancreas Transpl...
  Angelika C. Gruessner, Mark R. Laftavi, O. Pankewycz, Rainer W.G. Gruessner> ;Current Diabetes Reports. 2017 May 6
• 3 citations
  Combined induction therapy with rabbit antithymocyte globulin and rituximab in highly sensitized renal recipients.
  Mark R. Laftavi, Oleh Pankewycz, L. Feng, Meriem Said, Sunil Patel> ;Immunological Investigations. 2015 May 5
• 2 citations
  Urinary obstruction from lymphocele
  Rajeev Sharma, Sunil Patel, Mark R. Laftavi, Mareena Zachariah> ;Kidney International. 2015 Jan 1
• 10 citations
  Induction therapy in renal transplant recipients: a review.
  Mark R. Laftavi, Rajeev Sharma, Lin Feng, M. Said, Oleh Pankewycz> ;Immunological Investigations. 2014 Oct 8
• 6 citations
  The increasing clinical importance of alloantibodies in kidney transplantation.
  Oleh Pankewycz, Karim M Soliman, Mark R. Laftavi> ;Immunological Investigations. 2014 Oct 8
• 6 citations
  Long-term outcomes following sirolimus conversion after renal transplantation.
  Karim M Soliman, Emad Mogadam, Mark R. Laftavi, Sunil Patel, Lin Feng, M. Said, Oleh Pankewycz> ;Immunological Investigations. 2014 Oct 8
• 1 citations
  Long-Term Outcomes of Pancreas After Kidney Transplantation in Small Centers: Is It Justified?
  M. R. Laftavi, Oleh Pankewycz, Angelika C. Gruessner, Murray Brian, R. Kohli, L. Feng, M. Said, Ranu Sharma, Sangita P Patel> ;Transplantation Proceedings. 2014 Jul 1
• 3 citations
  Inhibiting Wipf2 downregulation by transgenic expression of its 3' mRNA-untranslated region improves cytotoxicity and vaccination response.
  Oleh Pankewycz, Long Shen, Jingxiu Xuan, Hong Li, Jing Wu, Li-Wu Guo, L. Feng, Mark R. Laftavi> ;European Journal of Immunology. 2012 Sep 1
• 7 citations
  Universal perioperative antimicrobial prophylaxis is not necessary in kidney transplantation.
  Mark R. Laftavi, Rezvan Rostami, Sunil Patel, R. Kohli, Helia Laftavi, Lin Feng, M. Said, Merril T. Dayton, Oleh Pankewycz> ;Clinical Transplantation. 2012 May 1
• 5 citations
  Mycophenolic acid dose reductions result in poor long-term renal allograft survival: comparison between mycophenolate sodium and mycophenolate mofetil.
  M. R. Laftavi, F. Hai, H. Laftavi, L. Feng, M. Said, S. K. Patel, R. Kohli, Muna A Alnimri, Michael R. Dayton, Oleh Pankewycz> ;Transplantation Proceedings. 2011 Mar 1
• 74 citations
  Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess effica...
  Mark R. Laftavi, R Stephan, Barbara Stefanick, R. Kohli, Fadi Dagher, Mary Applegate, John O'Keefe, Drew Pierce, Andrea Rubino, Haley Guzowski, Nicolae Leca, Merril T....> ;Surgery. 2005 Mar 1
• 15 citations
  Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation.
  R.K Kode, Kosunarty Fa, Shoaib Chowdhury, Karthik Ranganna, Billie Fyfe, Susan Stabler, A.M Damask, Mark R. Laftavi, Anil Kumar, Oleh Pankewycz> ;Clinical Transplantation. 2003 Aug 1
• 27 citations
  Diagnosis of pancreas rejection: cystoscopic transduodenal versus percutaneous computed tomography scan-guided biopsy.
  Mark R. Laftavi, Angelika C. Gruessner, Barbara Bland, Mary C. Foshager, James W. Walsh, David E.R. Sutherland, Rainer W.G. Gruessner> ;Transplantation. 1998 Feb 27
• Alemtuzumab and minimization immunotherapy in kidney transplantation: long-term results of comparison with rabbit anti-thymocyte globulin and standard triple maintenan...
  Zachariah, M.,Nader, N. D.,Brar, J.,Singh, N.,Venuto, R.,Patel, S.,Said, M.,Laftavi, M. R.,Pankewycz, O.> ;Transplant. Proc.. 2014 Feb 11
• Simulect, Neoral, Cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study.
  Kumar, M. S., Kode, R. K., Pankewycz, O. G., Laftavi, M. R., Kumar, A. M., Damask, A. M., Vora, M., Tomeny, M. B., Ferry, E., Samartino, B. C., Sierka, D., Lingaraju, ...> ;Transplant Proc. 2001 Nov 01
• Nine year experience with kidney transplantation in patients with positive hepatitis C virus antibody.
  Kode, R. K., Foster, C. E., Kumar, A. M., Vankawala, R., Damask, A. M., Fyfe, B. S., Seirka, D., Laftavi, M. R., Brezin, J., Pankewycz, O., Chvala, R., Kumar, M. S.> ;Transplant Proc. 2001 Feb 01
• Significance of pancreas graft biopsy in detection of rejection.
  Laftavi, M. R., Gruessner, A. C., Bland, B. J., Aideyan, O. A., Walsh, J. W., Sutherland, D. E., Gruessner, R. W.> ;Transplant Proc. 1998 Mar
• Photodynamic therapy can selectively eradicate pancreas exocrine secretion.
  Laftavi, M. R., Lens, P., Margonari, J., Cathingol, D., Dubernard, J. M., Martin, X.> ;Transplant Proc. 1998 Mar
• Diabetic polyneuropathy outcome after successful pancreas transplantation: 1 to 9 year follow up.
  Laftavi, M. R., Chapuis, F., Vial, C., Rahbar, M., Lefrancois, N., Feitosa, L. C., Dubernard, J. M., Martin, X.> ;Transplant Proc. 1995 Feb
• Pancreatic transplantation.
  Dubernard, J. M., Rahbar, M., Martin, X., Laftavi, M. R., Lefrancois, N.> ;Transplant Proc. 1995 Oct
• The role of antibiotic prophylaxis in the new era of immunosuppression.
  Laftavi, M. R., Rostami, R., Feng, L., Said, M., Kohli, R., Dayton, M., Pankewycz, O.> ;Transplant Proc. 2011 Mar
• Conversion to low-dose tacrolimus or rapamycin 3 months after kidney transplantation: a prospective, protocol biopsy-guided study.
  Pankewycz, O., Leca, N., Kohli, R., Weber-Shrikant, E., Said, M., Alnimri, M., Feng, L., Patel, S., Laftavi, M. R.> ;Transplant Proc. 2011 Mar
• African-American women and older patients are at risk for a greater decline in renal function following living kidney donation.
  Alnimri, M., Laftavi, M. R., Kohli, R., Said, M., Feng, L., Patel, S., Pankewycz, O.> ;Transplant Proc. 2011 Mar
• Join now to see all